HAVCR2 and chronic myelogenous leukemia, BCR-ABL1 positive: Bruck et al. identified increased expression of TIM-3, PD-1 and CTLA-4 on CD4+ and CD8+ T cells in the bone marrow of CML patients, compared with control samples [41].